Campion, Jonathan and Hewitt, Jed and Shiers, David and Taylor, David (2017) Pharmacy guidance on smoking and mental disorder. London: Royal College of Psychiatrists, National Pharmacy Association and Royal Pharmaceutical Society.
Preview | Title | Contact |
---|---|---|
|
PDF (Pharmacy guidance on smoking)
533kB |
• Smoking is the single largest cause of preventable death in the UK and a major determinant of health inequality for those with a mental disorder.
• With appropriate support, those with a mental disorder are able to stop smoking.
• Doses of some psychiatric medication require significant reduction following smoking cessation.
• A range of pharmacological interventions (such as combination nicotine replacement therapy or varenicline) and non-pharmacological interventions are effective in supporting smoking cessation for people with a mental disorder.
• Pharmacists have a key role in improving access to smoking cessation and reduction interventions for smokers with a mental disorder as well as facilitating appropriate changes of medication doses.
Pharmacists are ideally placed:
• to encourage patients to stop smoking,
• to explain the benefits of smoking cessation
• to support smoking reduction as a first step to cessation promoting a healthier lifestyle
• to counsel patients on the lifestyle change
• to facilitate change to patients’ medication doses where appropriate
Repository Staff Only: item control page